文献速递肝病

基于细胞的cccDNA报告基因检测结合功能基因组学鉴定YBX1为HBV cccDNA宿主因子及抗病毒候选靶点

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target.
PubMed 文献 · Gut · 2022-12-09

研究建立基于细胞的HBV cccDNA报告基因检测方法,对239个编码人类DNA损伤应答机制的基因进行功能缺失筛选,鉴定出27个候选cccDNA宿主因子,包括YBX1;在真实感染模型中沉默YBX1可稳健降低HBV cccDNA水平,患者中YBX1表达与HBV载量及肝病进展相关。

要点

  • 建立基于细胞的HBV cccDNA报告基因检测,以稳健的ELISA定量cccDNA水平。
  • 功能缺失筛选239个DNA损伤应答基因,鉴定27个候选cccDNA宿主因子,包括YBX1。
  • 真实感染模型中沉默YBX1稳健降低HBV cccDNA水平;患者中YBX1表达与HBV载量及肝病进展相关。

核心结论

  • 基于细胞的报告基因检测可用于发现HBV cccDNA宿主因子(包括YBX1),并适用于cccDNA相关宿主因子、抗病毒靶点及化合物的表征。

研究设计与样本

  • 建立基于细胞的HBV cccDNA报告基因检测方法,并对239个编码人类DNA损伤应答机制的基因进行功能缺失筛选。

主要发现

  • 报告基因检测以稳健的ELISA为读出,可定量cccDNA水平。
  • 功能缺失筛选鉴定出27个候选cccDNA宿主因子,包括Y box结合蛋白1(YBX1)。
  • 真实感染模型验证显示沉默YBX1后HBV cccDNA水平稳健下降。
  • 患者中YBX1表达与HBV载量及肝病进展稳健相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Chronic hepatitis B virus (HBV) infection is a leading cause of liver disease and hepatocellular carcinoma. A key feature of HBV replication is the synthesis of the covalently close circular (ccc)DNA, not targeted by current treatments and whose elimination would be crucial for viral cure. To date, little is known about cccDNA formation. One major challenge to address this urgent question is the absence of robust models for the study of cccDNA biology. DESIGN: We established a cell-based HBV cccDNA reporter assay and performed a loss-of-function screen targeting 239 genes encoding the human DNA damage response machinery. RESULTS: Overcoming the limitations of current models, the reporter assay enables to quantity cccDNA levels using a robust ELISA as a readout. A loss-of-function screen identified 27 candidate cccDNA host factors, including Y box binding protein 1 (YBX1), a DNA binding protein regulating transcription and translation. Validation studies in authentic infection models revealed a robust decrease in HBV cccDNA levels following silencing, providing proof-of-concept for the importance of YBX1 in the early steps of the HBV life cycle. In patients, YBX1 expression robustly correlates with both HBV load and liver disease progression. CONCLUSION: Our cell-based reporter assay enables the discovery of HBV cccDNA host factors including YBX1 and is suitable for the characterisation of cccDNA-related host factors, antiviral targets and compounds.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Verrier ER, Ligat G, Heydmann L, et al. Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target. Gut. 2022. PMID: 36591611. doi:10.1136/gutjnl-2020-323665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。